|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-3-17
|
|
pubmed:abstractText |
The role of semaphorins in tumor progression is still poorly understood. In this study, we aimed at elucidating the regulatory role of semaphorin 3A (SEMA3A) in primary tumor growth and metastatic dissemination.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1524-4636
|
|
pubmed:author |
pubmed-author:AnderssonFredrikF,
pubmed-author:CapparucciaLorenaL,
pubmed-author:CarmelietPeterP,
pubmed-author:CasazzaAndreaA,
pubmed-author:De PalmaMicheleM,
pubmed-author:GiustacchiniAliceA,
pubmed-author:JohanssonIrjaI,
pubmed-author:LarssonErikE,
pubmed-author:MazzoneMassimilianoM,
pubmed-author:NaldiniLuigiL,
pubmed-author:RAJR SRS,
pubmed-author:RolnyCharlotteC,
pubmed-author:SquadritoMario LeonardoML,
pubmed-author:TamagnoneLucaL,
pubmed-author:VenneriMary AnnaMA
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
741-9
|
|
pubmed:meshHeading |
pubmed-meshheading:21205984-Animals,
pubmed-meshheading:21205984-Breast Neoplasms,
pubmed-meshheading:21205984-Cell Hypoxia,
pubmed-meshheading:21205984-Cell Line, Tumor,
pubmed-meshheading:21205984-Cell Movement,
pubmed-meshheading:21205984-Cell Proliferation,
pubmed-meshheading:21205984-Female,
pubmed-meshheading:21205984-Gene Therapy,
pubmed-meshheading:21205984-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:21205984-Humans,
pubmed-meshheading:21205984-Lung Neoplasms,
pubmed-meshheading:21205984-Mice,
pubmed-meshheading:21205984-Mice, Inbred BALB C,
pubmed-meshheading:21205984-Necrosis,
pubmed-meshheading:21205984-Neovascularization, Pathologic,
pubmed-meshheading:21205984-Neuropilin-1,
pubmed-meshheading:21205984-Paracrine Communication,
pubmed-meshheading:21205984-RNA Interference,
pubmed-meshheading:21205984-Receptor, TIE-2,
pubmed-meshheading:21205984-Recombinant Fusion Proteins,
pubmed-meshheading:21205984-Semaphorin-3A,
pubmed-meshheading:21205984-Signal Transduction,
pubmed-meshheading:21205984-Stem Cells,
pubmed-meshheading:21205984-Stromal Cells,
pubmed-meshheading:21205984-Time Factors,
pubmed-meshheading:21205984-Transfection,
pubmed-meshheading:21205984-Tumor Burden,
pubmed-meshheading:21205984-Xenograft Model Antitumor Assays
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Systemic and targeted delivery of semaphorin 3A inhibits tumor angiogenesis and progression in mouse tumor models.
|
|
pubmed:affiliation |
Institute for Cancer Research and Treatment, University of Turin School of Medicine, Candiolo, Italy.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
